PHYSICAL THERAPY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM A GERMAN CLAIMS DATA ANALYSIS

被引：0
|
作者：
Barthuber, L. [1 ]
Nill, I [1 ]
Jacob, C. [2 ]
Schmid, T. [1 ]
机构：
[1] MSD Sharp & Dohme GmbH, Munich, By, Germany
[2] Xcenda GmbH, Hannover, Germany
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD44
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [1] CURRENT PHARMACEUTICAL TREATMENT LANDSCAPE OF PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS IN GERMANY: A CLAIMS DATA ANALYSIS
    Barthuber, L.
    Nill, I
    Jacob, C.
    Schmid, T.
    VALUE IN HEALTH, 2024, 27 (12) : S338 - S339
  • [2] Identification of pulmonary arterial hypertension (PAH) cases in automated claims data: A pilot study
    Oliveria, Susan A.
    Primatesta, Paola
    Yood, Marianne Ulcickas
    Wei, Feifei
    Robinson, Scott
    Wells, Karen
    Cajigas, Hector
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S243 - S243
  • [3] Targeted Therapy of pulmonary arterial Hypertension (PAH)
    Klose, H.
    Opitz, C.
    Bremer, H.
    Ewert, R.
    Bonderman, D.
    Rosenkranz, S.
    Seeger, W.
    Schmeisser, A.
    Harbaum, L.
    Buerke, M.
    Ghofrani, H. Ardeschir
    Borst, M. M.
    Leuchte, H. H.
    Lange, T. J.
    Behr, J.
    Ulrich, S.
    Lang, I.
    Olschewski, H.
    Gall, H.
    Kabitz, H. -J.
    Kleber, F. -X.
    Held, M.
    Hoeper, M. M.
    Gruenig, E.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S142 - S150
  • [4] Survival in patients with pulmonary arterial hypertension: data from the registry - single PAH centre
    Selimovic, N.
    Andersson, B.
    Bech-Hanssen, O.
    Rundqvist, B.
    EUROPEAN HEART JOURNAL, 2011, 32 : 437 - 437
  • [5] Sequential combination therapy in pulmonary arterial hypertension (PAH)
    Keogh, A.
    Kotlyar, E.
    Macdonald, P.
    Hayward, C.
    Corrigan, C.
    Pidoux, A.
    Brown, K.
    Williams, T.
    Gabbay, E.
    McNeil, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S186 - S186
  • [6] Cicletanine Therapy Is Well Tolerated in Patients with Advanced Pulmonary Arterial Hypertension (PAH)
    Waxman, A. B.
    Lawler, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [7] Accelerometry and Patterns of Physical Activity in Pulmonary Arterial Hypertension (PAH)
    Minhas, J.
    Shou, H.
    Hershman, S.
    Zamanian, R. T.
    Ventetuolo, C. E.
    Bull, T. M.
    Hemnes, A.
    Chakinala, M. M.
    Mathai, S. C.
    Al-Naamani, N.
    Matura, L.
    Kawut, S. M.
    Shcherbina, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [8] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
    Kremers, Hilal Maradit
    Slusser, Joshua P.
    Scott, Christopher G.
    Primatesta, Paola
    McGoon, Michael D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
  • [9] Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
    Escribano, P.
    Gaine, S.
    Biedermann, P.
    Muller, A.
    Valge, M.
    Lange, T.
    Soderberg, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S109 - S109
  • [10] Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)
    Charoenpong, Prangthip
    Dhillon, Navneet
    Murnane, Kevin
    Goeders, Nicholas
    Hall, Nicole
    Keller, Courtney
    Bhuiyan, Mohammad Alfrad Nobel
    Walter, Robert
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
12345